Skip to main content
. 2021 Nov 13;6(6):100303. doi: 10.1016/j.esmoop.2021.100303

Figure 3.

Figure 3

Sensitivity analyses—Tornado diagrams.

Tornado diagrams for deterministic sensitivity analysis depicting results of changes in selected variables per adjuvant systemic treatment therapy. (A) Nivolumab versus routine surveillance. (B) Pembrolizumab versus routine surveillance. (C) Dabrafenib-trametinib versus routine surveillance. Each bar represents a range of expected decrease (blue) or increase (red) in value per variable. Results are presented in ICERs. ICER, incremental cost-effectiveness ratio; NED, no evidence of disease; RPD, recurrent/progressive disease.